Vaginal progesterone decreases preterm birth &lt; 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the opptimum study

Romero R.; Nicolaides K. H.; Conde-Agudelo A.; O’Brien J. M.; Cetingoz E.; Fonseca E. da; Creasy G. W.; Hassan S. S.

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

685

Ultima descărcare din IBN:
2020-07-18 04:43

Căutarea după subiecte
similare conform CZU

618.39-021.3:615.256.52-08 (1)

Științe medicale. Medicină (11129)

Medicamentele potrivit acţiunii lor principale (394)

SM ISO690:2012

ROMERO, R., NICOLAIDES, K. H., CONDE-AGUDELO, A., O’BRIEN, J. M., CETINGOZ, E., FONSECA, E. da, CREASY, G. W., HASSAN, S. S.. Vaginal progesterone decreases preterm birth < 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the opptimum study. In: Buletin de Perinatologie, 2017, nr. 4(76), pp. 27-38. ISSN 1810-5289.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Buletin de Perinatologie

Numărul 4(76) / 2017 / ISSN 1810-5289

Vaginal progesterone decreases preterm birth < 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the opptimum study

CZU: 618.39-021.3:615.256.52-08

Pag. 27-38

Romero R.¹²³⁴, Nicolaides K. H.⁵, Conde-Agudelo A.¹, O’Brien J. M.⁶, Cetingoz E.³², Fonseca E. da², Creasy G. W.⁷, Hassan S. S.¹⁸

¹ National Institutes of Health, Department of Health and Human Services, Bethesda,
² Michigan State University,
³ University of Michigan,
⁴ Wayne State University,
⁵ King’s College Hospital,
⁶ University of Kentucky, Lexington,
⁷ Center for Biomedical Research,Population Council, New York,
⁸ Universidade Federal de Sao Paulo

Disponibil în IBN: 17 februarie 2018

Descarcă PDF

Rezumat

This updated systematic review and meta- analysis reaffirms that vaginal progesterone reduces the risk of preterm birth and neonatal morbidity and mortality in women with a singleton gestation and a mid-trimester CL < 25 mm, without any deleterious effects on neurodev- elopmental outcome. Clinicians should continue to per form universal transvaginal CL screening at 18-24 weeks of gestation in women with a singleton gestation and to offer vaginal progesterone to those with a CL < 25 mm. Published 2016. This article is a U.S. Government work and is in the public domain in the USA

Cuvinte-cheie
cervical length, neonatal morbidity, progestins, progestogens,

neonatal mortality, prematurity, preterm delivery, transvaginal ultrasound